• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非功能性垂体腺瘤伴视交叉受压患者的护理质量评估:基于系统文献回顾和队列研究的视觉结局和干预时机的临床推荐。

Quality of care evaluation in non-functioning pituitary adenoma with chiasm compression: visual outcomes and timing of intervention clinical recommendations based on a systematic literature review and cohort study.

机构信息

Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.

Center for Endocrine Tumors Leiden, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Pituitary. 2020 Aug;23(4):417-429. doi: 10.1007/s11102-020-01044-0.

DOI:10.1007/s11102-020-01044-0
PMID:32419072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7316692/
Abstract

PURPOSE

Surgery in patients with non-functioning pituitary macroadenomas (NFMA) is effective in ameliorating visual function. The urgency for decompression, and preferred timing of surgery related to the preoperative severity of dysfunction is unknown.

METHODS

Systematic review for evidence to provide clinical guidance for timing of surgical decompression of the optic chiasm, and a cohort study of 30 NFMA patients, in whom mean deviation (MD), and severity of visual dysfunction was assessed.

RESULTS

Systematic review 44 studies were included with a total of 4789 patients. Postoperatively, visual field defects improved in 87.0% of patients, stabilized in 12.8% and worsened in 1.0%. Specific protocols regarding timing of surgery were not reported. Only seven studies (16.7%) reported on either the duration of visual symptoms, or diagnostic, or treatment delay. Cohort study 30 NFMA patients (50% female, 60 eyes, mean age 58.5 ± 14.8 years), had a median MD of - 5.3 decibel (IQR - 3.1 to - 10.1). MD was strongly correlated with clinical severity (r =  - 0.94, P < 0.0001), and were used for severity of defects cut-off values: (1) normal >  - 2 dB, (2) mild - 2 dB to - 4 dB, (3) moderate - 4 to - 8 dB, (4) severe - 8 to - 17 dB, (5) very severe <  - 17 dB.

CONCLUSION

Surgical decompression is highly effective in improving visual function. Uniform, quantitative grading of visual dysfunction was lacking. MD is a promising quantitative outcome measure. We provide recommendations for the evaluation of timing of surgery, considering severity of visual impairment, which will need further validation based on expert clinical practice.

摘要

目的

对于无功能垂体大腺瘤(NFMA)患者,手术可有效改善视觉功能。目前尚不清楚减压的紧迫性和与术前功能障碍严重程度相关的手术最佳时机。

方法

系统回顾证据,为视神经交叉减压手术时机提供临床指导,并对 30 例 NFMA 患者进行队列研究,评估平均偏差(MD)和视觉功能障碍的严重程度。

结果

系统回顾纳入了 44 项研究,共 4789 例患者。术后,87.0%的患者视野缺损改善,12.8%的患者稳定,1.0%的患者恶化。没有报道具体的手术时机方案。只有 7 项研究(16.7%)报告了视觉症状的持续时间、诊断或治疗延迟。队列研究纳入 30 例 NFMA 患者(50%为女性,60 只眼,平均年龄 58.5±14.8 岁),平均 MD 值为-5.3 分贝(IQR-3.1 至-10.1)。MD 与临床严重程度呈强相关性(r=−0.94,P<0.0001),并用于缺陷严重程度的截断值:(1)正常>−2 分贝,(2)轻度−2 至−4 分贝,(3)中度−4 至−8 分贝,(4)重度−8 至−17 分贝,(5)非常严重<−17 分贝。

结论

手术减压对视功能的改善非常有效。缺乏统一的、量化的视觉功能障碍分级。MD 是一种很有前途的量化预后指标。我们根据视觉损害的严重程度提出了手术时机评估的建议,这需要进一步基于专家临床实践进行验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd9/7316692/42f6b87aea00/11102_2020_1044_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd9/7316692/3e8d80c71395/11102_2020_1044_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd9/7316692/42f6b87aea00/11102_2020_1044_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd9/7316692/3e8d80c71395/11102_2020_1044_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd9/7316692/42f6b87aea00/11102_2020_1044_Fig2_HTML.jpg

相似文献

1
Quality of care evaluation in non-functioning pituitary adenoma with chiasm compression: visual outcomes and timing of intervention clinical recommendations based on a systematic literature review and cohort study.非功能性垂体腺瘤伴视交叉受压患者的护理质量评估:基于系统文献回顾和队列研究的视觉结局和干预时机的临床推荐。
Pituitary. 2020 Aug;23(4):417-429. doi: 10.1007/s11102-020-01044-0.
2
Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression.垂体大腺瘤患者视力丧失发展的预测因素及视神经减压后视力恢复的预测因素。
Can J Ophthalmol. 2010 Aug;45(4):404-8. doi: 10.3129/i09-276.
3
The Chiasmal Compression Index: An Integrative Assessment Tool for Visual Disturbances in Patients with Pituitary Macroadenomas.视交叉压迫指数:一种评估垂体大腺瘤患者视觉障碍的综合评估工具。
World Neurosurg. 2020 Nov;143:e44-e50. doi: 10.1016/j.wneu.2020.06.086. Epub 2020 Jun 17.
4
[Outcome of visual acuity after surgical removal of pituitary adenomas].[垂体腺瘤手术切除后的视力结果]
Srp Arh Celok Lek. 2013 May-Jun;141(5-6):296-303. doi: 10.2298/sarh1306296g.
5
Factors Influencing Visual Field Recovery after Transsphenoidal Resection of a Pituitary Adenoma.垂体腺瘤经蝶窦切除术后视野恢复的影响因素
Korean J Ophthalmol. 2018 Dec;32(6):488-496. doi: 10.3341/kjo.2017.0094.
6
Surgical results of large and giant pituitary adenomas with special consideration of ophthalmologic outcomes.大及巨大垂体腺瘤的手术治疗结果,特别考虑眼科学结果。
World Neurosurg. 2011 Jul-Aug;76(1-2):141-8; discussion 63-6. doi: 10.1016/j.wneu.2011.02.009.
7
Prognostic factors for visual recovery after transsphenoidal pituitary adenectomy.经蝶窦垂体腺瘤切除术后视力恢复的预后因素。
Br J Neurosurg. 2013 Aug;27(4):425-9. doi: 10.3109/02688697.2013.767316. Epub 2013 Feb 19.
8
An Analysis of Retinal Nerve Fiber Layer Thickness before and after Pituitary Adenoma Surgery and its Correlation with Visual Acuity.垂体瘤手术后视网膜神经纤维层厚度的分析及其与视力的相关性。
Neurol India. 2020 Mar-Apr;68(2):346-351. doi: 10.4103/0028-3886.280634.
9
Visual outcome of surgically managed pituitary adenomas followed-up at the Yaoundé Central Hospital.在雅温得中心医院接受随访的手术治疗垂体腺瘤的视觉预后。
Br J Neurosurg. 2018 Oct;32(5):521-527. doi: 10.1080/02688697.2018.1498449. Epub 2018 Aug 3.
10
Prognostic value of radial peripapillary capillary density for visual field outcomes in pituitary adenoma: A case-control study.垂体腺瘤患者视盘周围放射状毛细血管密度对视野结果的预后价值:病例对照研究。
J Clin Neurosci. 2022 Jun;100:113-119. doi: 10.1016/j.jocn.2022.04.012. Epub 2022 Apr 18.

引用本文的文献

1
Comparison of gadobutrol and meglumine gadoterate for dynamic contrast-enhanced MRI of pituitary macroadenomas.钆布醇与葡甲胺钆喷酸在垂体大腺瘤动态对比增强磁共振成像中的比较。
Sci Rep. 2025 Jul 21;15(1):26419. doi: 10.1038/s41598-025-10702-x.
2
Predictive Value of Blood Markers in Nonfunctional Pituitary Adenomas using Artificial Neural Network.使用人工神经网络评估血液标志物在无功能垂体腺瘤中的预测价值
Adv Biomed Res. 2023 Mar 28;12:83. doi: 10.4103/abr.abr_183_21. eCollection 2023.
3
Clinical presentation and recurrence of pituitary neuroendocrine tumors: results from a single referral center in Colombia.

本文引用的文献

1
The Microenvironment of Pituitary Tumors-Biological and Therapeutic Implications.垂体肿瘤的微环境——生物学及治疗意义
Cancers (Basel). 2019 Oct 21;11(10):1605. doi: 10.3390/cancers11101605.
2
MANAGEMENT OF ENDOCRINE DISEASE: Visual morbidity in patients with pituitary adenoma.内分泌疾病管理:垂体腺瘤患者的视觉发病率。
Eur J Endocrinol. 2019 Nov;181(5):R185-R197. doi: 10.1530/EJE-19-0349.
3
Toward Value Based Health Care in pituitary surgery: application of a comprehensive outcome set in perioperative care.朝着基于价值的垂体外科医疗保健迈进:围手术期护理中综合结局集的应用。
垂体神经内分泌肿瘤的临床表现与复发:来自哥伦比亚一家转诊中心的结果
J Endocrinol Invest. 2023 Nov;46(11):2275-2286. doi: 10.1007/s40618-023-02080-w. Epub 2023 Mar 31.
4
Visual field improvement after endoscopic transsphenoidal surgery in patients with pituitary adenoma.垂体腺瘤患者经蝶窦内镜手术后的视野改善情况。
Front Oncol. 2023 Feb 15;13:1108883. doi: 10.3389/fonc.2023.1108883. eCollection 2023.
5
Costs and Its Determinants in Pituitary Tumour Surgery.垂体瘤手术的成本及其决定因素。
Front Endocrinol (Lausanne). 2022 Jul 7;13:905019. doi: 10.3389/fendo.2022.905019. eCollection 2022.
6
Dopamine Agonists in the Management of Non-Functioning Pituitary Adenomas.多巴胺激动剂在无功能垂体腺瘤治疗中的应用
Acta Endocrinol (Buchar). 2021 Jul-Sep;17(3):377-382. doi: 10.4183/aeb.2021.377.
7
Chiasmal herniation following treatment of pituitary macroadenoma.垂体大腺瘤治疗后的视交叉疝
Pituitary. 2021 Feb;24(1):68-78. doi: 10.1007/s11102-020-01088-2. Epub 2020 Oct 15.
Eur J Endocrinol. 2019 Oct;181(4):375-387. doi: 10.1530/EJE-19-0344.
4
Visual loss and recovery in chiasmal compression.视交叉受压后的视力丧失与恢复。
Prog Retin Eye Res. 2019 Nov;73:100765. doi: 10.1016/j.preteyeres.2019.06.001. Epub 2019 Jun 14.
5
Characteristics of Preoperative Visual Disturbance and Visual Outcome After Endoscopic Endonasal Transsphenoidal Surgery for Nonfunctioning Pituitary Adenoma in Elderly Patients.老年患者内镜经鼻蝶窦入路垂体无功能腺瘤术前视觉障碍的特点及术后视觉转归。
World Neurosurg. 2019 Jun;126:e706-e712. doi: 10.1016/j.wneu.2019.02.132. Epub 2019 Mar 5.
6
Visual Field Outcome Reporting in Neurosurgery: Lessons Learned from a Prospective, Multicenter Study of Transsphenoidal Pituitary Surgery.神经外科手术中的视野结果报告:经蝶窦垂体手术前瞻性多中心研究的经验教训
World Neurosurg. 2018 Dec;120:e326-e332. doi: 10.1016/j.wneu.2018.08.069. Epub 2018 Aug 23.
7
The Predictive Value of Suprasellar Extension for Visual Function Evaluation in Chinese Patients with Nonfunctioning Pituitary Adenoma with Optic Chiasm Compression.鞍上扩展对中国非功能性垂体腺瘤伴视交叉受压患者视觉功能评估的预测价值
World Neurosurg. 2018 Aug;116:e960-e967. doi: 10.1016/j.wneu.2018.05.141. Epub 2018 May 29.
8
Predictive factors of visual function recovery after pituitary adenoma resection: a literature review and Meta-analysis.垂体腺瘤切除术后视觉功能恢复的预测因素:文献综述与Meta分析
Int J Ophthalmol. 2017 Nov 18;10(11):1742-1750. doi: 10.18240/ijo.2017.11.17. eCollection 2017.
9
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement.垂体肿瘤卓越中心(PTCOE)的定义标准:垂体学会声明。
Pituitary. 2017 Oct;20(5):489-498. doi: 10.1007/s11102-017-0838-2.
10
Risks and Benefits of Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas in Patients of the Ninth Decade.九十岁患者非功能性垂体腺瘤经蝶窦内镜手术的风险与益处
World Neurosurg. 2017 Oct;106:315-321. doi: 10.1016/j.wneu.2017.06.151. Epub 2017 Jul 1.